Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Cogent Biosciences (COGT) has a market cap of $0.91 billion USD. According to our data, Cogent Biosciences is ranked No.5352 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $0.91 B |
5.13%
|
| Dec 31, 2024 | $0.86 B |
32.65%
|
| Dec 29, 2023 | $0.65 B |
-49.13%
|
| Dec 30, 2022 | $1.28 B |
34.73%
|
| Dec 31, 2021 | $0.95 B |
-23.60%
|
| Dec 31, 2020 | $1.24 B |
289.93%
|
| Dec 31, 2019 | $0.32 B |
-83.64%
|
| Dec 31, 2018 | $1.94 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
 Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
USA
|
 Relay Therapeutics
RLAY
|
$0.82 B |
0.000 M
|
USA
|
 Kura Oncology
KURA
|
$0.61 B |
0.000 M
|
USA
|
 Zai Lab
ZLAB
|
$3.03 B |
0.125 B
|
China
|
 BeiGene
BGNE
|
$20.21 B |
-0.311 B
|
China
|
 Exelixis
EXEL
|
$9.39 B |
0.000 M
|
USA
|
 Array Technologies
ARRY
|
$0.97 B |
0.000 M
|
USA
|
 Agios Pharmaceuticals
AGIO
|
$1.94 B |
-0.000 M
|
USA
|
 Syndax Pharmaceuticals
SNDX
|
$1.20 B |
0.000 M
|
USA
|
 Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
 Arcus Biosciences
RCUS
|
$1.23 B |
-0.000 M
|
USA
|
| Market Cap | = | COGT Stock Price | * | COGT Shares Outstanding |
| = | $8.20 | * | 0.11 B | |
| = | $0.91 B |